[Pharmacological study on thiocarboxamides with antisecretory and ulceroprotective properties].
D000577:Amides / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D004285:Dogs; D005260:Female; D005750:Gastric Juice / Q000032:analysis / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010276:Parasympatholytics / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D010437:Peptic Ulcer / Q000517:prevention & control*; D010653:Phenylbutazone / Q000037:antagonists & inhibitors; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced; D013440:Sulfides / Q000494:pharmacology
D000577:Amides; D010276:Parasympatholytics; D013440:Sulfides; D010653:Phenylbutazone
Etude pharmacologique de thiocarboxamides anti-sécrétoires gastriques et ulcero-propectrices.